AGH Wealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$417K Buy
2,870
+29
+1% +$4.01K 0.24% 79
2026
Q2
$365K Buy
2,841
+74
+3% +$8.66K 0.23% 82
2026
Q1
$333K Buy
2,767
+355
+15% +$41K 0.25% 82
2025
Q4
$254K Sell
2,412
-532
-18% -$49.9K 0.19% 95
2025
Q3
$247K Buy
2,944
+1
+0% +$82 0.18% 102
2025
Q2
$233K Buy
2,943
+16
+0.5% +$1.27K 0.19% 111
2025
Q1
$263K Sell
2,927
-375
-11% -$35K 0.25% 92
2024
Q4
$328K Buy
+3,302
New +$340K 0.3% 77

Other funds holding MRK

AGH Wealth Advisors's MRK Position: Q3 2026 in Review

AGH Wealth Advisors increased its Merck (MRK) stake by 1% in Q3 2026, buying an estimated $4.01K and bringing the position to 2,870 shares worth $417K. The position accounts for 0.24% of the portfolio, ranked #79.

AGH Wealth Advisors first reported a position in MRK in Q4 2024 and has held it in 8 quarters since. 3,520 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • AGH Wealth Advisors held 2,870 shares of Merck worth $417K as of Q3 2026.
  • AGH Wealth Advisors bought 29 Merck shares in Q3 2026, an estimated $4.01K.
  • Merck made up 0.24% of AGH Wealth Advisors's portfolio in Q3 2026, its #79 holding.
  • AGH Wealth Advisors first reported a position in Merck in Q4 2024 and has held it in 8 quarters since.
  • 3,520 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on AGH Wealth Advisors's 13F filing for Q3 2026, filed 26 Oct 2026.